Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 14 Aug, 01:00 am
Brinker International (NYSE:EAT) Soars on Strong Q4 Results and Analyst Price Target Hike Analyst firm Stephens raised its price target for Brinker International (NYSE:EAT) to $300.00 , maintaining an " Overweight " rating, signaling strong confidence in the restaurant stock. The
Q2 Financial Underperformance: Global Crossing Airlines Group, Inc. reported an earnings per share of -$0.01 and revenue of $62.02 million , both falling short of analyst estimates. Profitability Decline: Despite a 1% revenue growth , the company experienced a significant 58% dec
Marvell Technology (NASDAQ:MRVL) maintains a strong market position in AI data centers and optical networking chips , further bolstered by its custom chip programs . Investment firm Goldman Sachs reaffirmed its Neutral rating on Marvell Technology but raised its price target to $
A Merck officer completed a significant stock sale totaling approximately $1.46 million . The company demonstrated strong stock performance , with shares rising 5.6% and Q2 revenues growing 5% to $16.61 billion . Despite recent success, Merck faces challenges including lowered ad
SKYX Platforms Corp. reported an EPS miss at -$0.06 but demonstrated robust revenue growth , reaching $25.30 million , surpassing analyst estimates. Despite not yet being profitable (negative P/E ratio of -4.03 ), the company significantly reduced cash used in operations by 39% a
Analyst firm Jefferies increased its price target for Ryman Hospitality Properties (NYSE: RHP) to $145.00 , suggesting a potential upside of 16.94% . The company demonstrates strong operational results, including record Revenue Per Available Room (RevPAR) and 22% year-over-year g
Apple (NASDAQ: AAPL) Downgraded to Underperform Amid iPhone and Profitability Concerns Jefferies downgraded Apple from Hold to Underperform and lowered its price target to $263.66 . The firm cited concerns about Apple’s future iPhone pricing strategy amid rising memory and
Pfizer is strategically shifting its business focus from pandemic-era COVID-19 products to its robust non-COVID portfolio, aiming for sustainable future growth. The company demonstrated strong operational performance in Q2 2026, with non-COVID revenues growing by 5% and an impres
Strong Financial Performance: Coherent Corp. reported robust Q4 revenue and EPS, exceeding analyst expectations. AI-Driven Growth: The company's success is significantly boosted by increasing demand for its AI-related technologies and optical communications. Healthy Financials: C
Dell Technologies (NYSE: DELL) led the tech sector's strong performance, with its AI server business growing by an impressive 757% . Several other technology companies, including Nokia (NYSE: NOK) , Hewlett Packard Enterprise (NYSE: HPE) , Resideo Technologies, Inc. (NYSE: REZI)
Some stocks, such as XMAX, Inc., saw drops despite announcing positive developments like major artificial intelligence service agreements, illustrating the complex nature of market reactions. Other notable stock declines were directly linked to specific events, including legal in
Jefferies reaffirmed its "Buy" rating for Global-e Online, highlighting confidence in the e-commerce platform's future. The company reported robust second-quarter financial performance, surpassing analyst expectations for both revenue and earnings per share (EPS). Global-e Online
Riskified Ltd. reported mixed Q2 2026 earnings per share (EPS) , surpassing some analyst estimates but missing the Zacks Consensus. The company demonstrated robust revenue growth of 22% year-over-year, exceeding expectations and marking its strongest growth in over four years. Ri
Safe Pro Group Inc. (NASDAQ:SPAI) Prepares for Q2 2026 Earnings Report Amidst AI Defense Growth Safe Pro Group Inc. (NASDAQ:SPAI) is scheduled to report its Q2 2026 quarterly earnings on August 13, 2026, focusing on AI-enabled defense and security solutions. Analysts project reve
Analysts have significantly raised the consensus price target for Outlook Therapeutics (NASDAQ:OTLK) , reflecting growing confidence in the biopharmaceutical company. This positive shift is driven by promising Phase III clinical trial results for ONS-5010 and strategic partnershi
Ball Corporation (NYSE: BALL) Stock Analysis: Growth Potential and Strong Financials Despite a recent pullback, Ball Corporation (NYSE: BALL)'s stock performance shows a monthly gain, potentially offering an investment opportunity. Analysts project a significant 20.27% growth pot
Kyndryl's recent stock performance shows a 30-day gain of 11.97% but a 10-day pullback of 3.77% , potentially offering an attractive entry point for investors. Analysts project significant stock price growth potential of 12.85% for Kyndryl, with a target price of $14.67 . The com
The Honest Company (NASDAQ:HNST) exceeded Q2 earnings expectations, reporting $0.04 per share , double the consensus estimate. Morgan Stanley raised its price target for The Honest Company to $5.70 , suggesting a potential 10.9% upside from its current stock price. Despite a tota
Headlines provided by Investing.com